v3.26.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Operating expenses:    
Acquired in-process research and development $ 8,517,966 $ 0
Research and development 368,170 770,027
General and administrative 3,727,816 4,964,289
Total operating expenses 12,613,952 5,734,316
Loss from operations (12,613,952) (5,734,316)
Interest income and other, net 95,472 158,539
Net loss (12,518,480) (5,575,777)
Loss attributable to common stockholders $ (12,518,480) $ (5,575,777)
Net loss per share attributable to common stockholders - basic $ (129.1) $ (69.54)
Net loss per share attributable to common stockholders - diluted (129.1) (69.54)
Total net loss per share - basic (129.1) (69.54)
Total net loss per share - diluted $ (129.1) $ (69.54)
Weighted-average number of common shares used in net loss per share attributable to common stockholders - basic 96,967 80,184
Weighted-average number of common shares used in net loss per share attributable to common stockholders - diluted 96,967 80,184